Staphylococcus pettenkoferi Bacteremia in an American Intensive Care Unit

Coagulase-negative staphylococci (CoNS) are considered the most common cause of nosocomial bloodstream infections; yet, these species are frequently designated as contaminants in the absence of systemic signs and symptoms of infection. Immunocompromised patients or those with prosthetic devices are...

Full description

Bibliographic Details
Main Authors: Cameron Strong, Michael Cosiano, Melanie Cabezas, J. W. Barwatt, L. Gayani Tillekeratne
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:Case Reports in Infectious Diseases
Online Access:http://dx.doi.org/10.1155/2021/5235691
id doaj-acdd80a1720846659e706a8a909e58ea
record_format Article
spelling doaj-acdd80a1720846659e706a8a909e58ea2021-10-11T00:39:16ZengHindawi LimitedCase Reports in Infectious Diseases2090-66332021-01-01202110.1155/2021/5235691Staphylococcus pettenkoferi Bacteremia in an American Intensive Care UnitCameron Strong0Michael Cosiano1Melanie Cabezas2J. W. Barwatt3L. Gayani Tillekeratne4Department of MedicineDepartment of MedicineDepartment of MedicineDepartment of MedicineDepartment of MedicineCoagulase-negative staphylococci (CoNS) are considered the most common cause of nosocomial bloodstream infections; yet, these species are frequently designated as contaminants in the absence of systemic signs and symptoms of infection. Immunocompromised patients or those with prosthetic devices are at increased risk for clinically significant bacteremia. With the advent of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) in clinical practice, there has been improved specificity of CoNS isolate identification and further elucidation of underrecognized pathogenic species. Staphylococcus pettenkoferi was a novel CoNS species first identified in 2002 and thought to be misdiagnosed as other CoNS due to limitations in biochemical identification. There is increasing identification of S. pettenkoferi isolates; however, there are limited case reports of clinically significant S. pettenkoferi bacteremia and no reported cases within the United States. We present the first known case of S. pettenkoferi from an American intensive care unit.http://dx.doi.org/10.1155/2021/5235691
collection DOAJ
language English
format Article
sources DOAJ
author Cameron Strong
Michael Cosiano
Melanie Cabezas
J. W. Barwatt
L. Gayani Tillekeratne
spellingShingle Cameron Strong
Michael Cosiano
Melanie Cabezas
J. W. Barwatt
L. Gayani Tillekeratne
Staphylococcus pettenkoferi Bacteremia in an American Intensive Care Unit
Case Reports in Infectious Diseases
author_facet Cameron Strong
Michael Cosiano
Melanie Cabezas
J. W. Barwatt
L. Gayani Tillekeratne
author_sort Cameron Strong
title Staphylococcus pettenkoferi Bacteremia in an American Intensive Care Unit
title_short Staphylococcus pettenkoferi Bacteremia in an American Intensive Care Unit
title_full Staphylococcus pettenkoferi Bacteremia in an American Intensive Care Unit
title_fullStr Staphylococcus pettenkoferi Bacteremia in an American Intensive Care Unit
title_full_unstemmed Staphylococcus pettenkoferi Bacteremia in an American Intensive Care Unit
title_sort staphylococcus pettenkoferi bacteremia in an american intensive care unit
publisher Hindawi Limited
series Case Reports in Infectious Diseases
issn 2090-6633
publishDate 2021-01-01
description Coagulase-negative staphylococci (CoNS) are considered the most common cause of nosocomial bloodstream infections; yet, these species are frequently designated as contaminants in the absence of systemic signs and symptoms of infection. Immunocompromised patients or those with prosthetic devices are at increased risk for clinically significant bacteremia. With the advent of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) in clinical practice, there has been improved specificity of CoNS isolate identification and further elucidation of underrecognized pathogenic species. Staphylococcus pettenkoferi was a novel CoNS species first identified in 2002 and thought to be misdiagnosed as other CoNS due to limitations in biochemical identification. There is increasing identification of S. pettenkoferi isolates; however, there are limited case reports of clinically significant S. pettenkoferi bacteremia and no reported cases within the United States. We present the first known case of S. pettenkoferi from an American intensive care unit.
url http://dx.doi.org/10.1155/2021/5235691
work_keys_str_mv AT cameronstrong staphylococcuspettenkoferibacteremiainanamericanintensivecareunit
AT michaelcosiano staphylococcuspettenkoferibacteremiainanamericanintensivecareunit
AT melaniecabezas staphylococcuspettenkoferibacteremiainanamericanintensivecareunit
AT jwbarwatt staphylococcuspettenkoferibacteremiainanamericanintensivecareunit
AT lgayanitillekeratne staphylococcuspettenkoferibacteremiainanamericanintensivecareunit
_version_ 1716829218624503808